Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning

被引:55
作者
Hanna, M [1 ]
Brault, M [1 ]
Kwan, T [1 ]
Kast, C [1 ]
Gros, P [1 ]
机构
[1] MCGILL UNIV,DEPT BIOCHEM,MONTREAL,PQ H3G 1Y6,CANADA
关键词
D O I
10.1021/bi951333p
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The biochemical and genetic analyses of P-glycoprotein (P-gp) have indicated that the membrane-associated regions of P-gp play an important role in drug recognition and drug transport. Predicted transmembrane domain 11 (TM11) maps near a major drug binding site revealed by photoaffinity labeling, and mutations in this domain alter the substrate specificity of P-gp. To investigate further the role of TM11 in P-gp function in general, and substrate specificity in particular, each of the 21 residues of TM11 of the P-gp isoform encoded by the mouse mdr3 gene was independently mutated to alanine, or to glycine in the case of endogenous alanines. After transfection and overexpression in Chinese hamster ovary cells, pools of stable transfectants were analyzed for qualitative or quantitative deviations from the profile of resistance to vinblastine, adriamycin, colchicine, and actinomycin D displayed by the wild-type protein. While mutations at eight of the positions had no effect on P-gp function, 13 mutants showed a 2-10-fold reduction of activity against one of the four drugs tested, Although the phenotype of individual mutants was varied, replacements at most mutation-sensitive positions seemed to affect the drug resistance profiles rather than the overall activity of the mutant P-gp. When TM11 was projected in a alpha-helical configuration, the distribution of deleterious and neutral mutations was not random but segregated with a more hydrophobic (mutation-insensitive) face and a more hydrophilic (mutation-sensitive) face of a putative amphipathic helix. The alternate clustering pattern of deleterious vs neutral mutations in TM11 together with the altered drug resistance profile of deleterious mutants suggest that the more hydrophilic face of the TM11 helix may play an important structural or functional role in drug recognition and transport by P-gp. Finally, the conservation of the two residues most sensitive to mutations (Y949 and F953) in TM11, and in the homologous TM5, of all mammalian P-gps and also in other ABC transporters, suggests that these residues and domains may play an important role in structural as well as mechanistic aspects common to this family of proteins.
引用
收藏
页码:3625 / 3635
页数:11
相关论文
共 63 条
[1]   THE PROBABLE ARRANGEMENT OF THE HELICES IN G-PROTEIN-COUPLED RECEPTORS [J].
BALDWIN, JM .
EMBO JOURNAL, 1993, 12 (04) :1693-1703
[2]  
BRUGGEMANN EP, 1989, J BIOL CHEM, V264, P15483
[3]  
BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020
[4]   FUNCTIONAL-ANALYSIS OF CHIMERIC GENES OBTAINED BY EXCHANGING HOMOLOGOUS DOMAINS OF THE MOUSE MDR1 AND MDR2 GENES [J].
BUSCHMAN, E ;
GROS, P .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (02) :595-603
[5]   INTERNAL DUPLICATION AND HOMOLOGY WITH BACTERIAL TRANSPORT PROTEINS IN THE MDR1 (P-GLYCOPROTEIN) GENE FROM MULTIDRUG-RESISTANT HUMAN-CELLS [J].
CHEN, CJ ;
CHIN, JE ;
UEDA, K ;
CLARK, DP ;
PASTAN, I ;
GOTTESMAN, MM ;
RONINSON, IB .
CELL, 1986, 47 (03) :381-389
[6]   AN ALTERED PATTERN OF CROSS-RESISTANCE IN MULTIDRUG-RESISTANT HUMAN-CELLS RESULTS FROM SPONTANEOUS MUTATIONS IN THE MDR1 (P-GLYCOPROTEIN) GENE [J].
CHOI, K ;
CHEN, C ;
KRIEGLER, M ;
RONINSON, IB .
CELL, 1988, 53 (04) :519-529
[7]   ATP-BINDING PROPERTIES OF P-GLYCOPROTEIN FROM MULTIDRUG-RESISTANT KB CELLS [J].
CORNWELL, MM ;
TSURUO, T ;
GOTTESMAN, MM ;
PASTAN, I .
FASEB JOURNAL, 1987, 1 (01) :51-54
[8]   MEMBRANE-VESICLES FROM MULTIDRUG-RESISTANT HUMAN CANCER-CELLS CONTAIN A SPECIFIC 150-KDA TO 170-KDA PROTEIN DETECTED BY PHOTOAFFINITY-LABELING [J].
CORNWELL, MM ;
SAFA, AR ;
FELSTED, RL ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) :3847-3850
[9]   2 MEMBERS OF THE MOUSE MDR GENE FAMILY CONFER MULTIDRUG RESISTANCE WITH OVERLAPPING BUT DISTINCT DRUG SPECIFICITIES [J].
DEVAULT, A ;
GROS, P .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (04) :1652-1663
[10]  
DEVEREUX J, 1991, GCG SEQUENCE ANAL SO